Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | BMRN | AXSM | ||
| Company | Arrowhead Pharma | Biomarin Pharmaceuticals | Axsome Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 69.21 | 54.53 | 188.33 | ||
| High | 70.48 | 55.57 | 191.00 | ||
| Low | 68.09 | 54.31 | 187.00 | ||
| Latest | 69.25 | 54.88 | 188.69 | ||
| Change | -0.26 | +0.24 | -0.30 | ||
| % Change | -0.37% | +0.44% | -0.16% | ||
| Volume | 1,198,600 | 1,598,500 | 525,100 | ||
| 20-Day Average Volume | 1,927,685 | 1,623,010 | 596,050 | ||
| Previous Close | 69.51 | 54.64 | 188.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 63.14 | 55.39 | 172.25 | ||
| 20-Day Raw Stochastic | 82.94% | 34.62% | 94.03% | ||
| 20-Day Relative Strength | 59.97 | 44.58 | 65.94 | ||
| Weighted Alpha | +285.39 | -11.72 | +82.54 | ||
| Today's Opinion | 72% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 72% Buy | 40% Sell | 100% Buy | ||
| Last Month's Opinion | 24% Buy | 8% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.56% since 04/13/26 | unch since 04/13/26 | +5.81% since 04/13/26 | ||
| Low | 63.98 on 04/14/26 | 53.79 on 04/16/26 | 178.33 on 04/14/26 | ||
| High | 72.18 on 04/16/26 | 56.05 on 04/15/26 | 191.00 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +22.94% since 03/20/26 | +1.39% since 03/20/26 | +20.25% since 03/20/26 | ||
| Low | 55.01 on 03/24/26 | 53.35 on 03/24/26 | 152.28 on 03/24/26 | ||
| High | 72.18 on 04/16/26 | 57.76 on 04/08/26 | 191.00 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +6.08% since 01/20/26 | -2.54% since 01/20/26 | +2.27% since 01/20/26 | ||
| Low | 54.02 on 03/13/26 | 53.35 on 03/24/26 | 152.28 on 03/24/26 | ||
| High | 76.11 on 02/03/26 | 66.28 on 02/24/26 | 191.50 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +80.01% since 10/20/25 | +3.41% since 10/20/25 | +43.38% since 10/20/25 | ||
| Low | 36.73 on 10/23/25 | 50.76 on 11/07/25 | 123.50 on 11/03/25 | ||
| High | 76.76 on 01/06/26 | 66.28 on 02/24/26 | 191.50 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,733,623 | 10,508,528 | 9,667,404 | ||
| Shares Outstanding, K | 140,032 | 192,323 | 51,153 | ||
| Annual Sales | 829,450,000 | 3,221,250,000 | 638,500,000 | ||
| Annual Net Income | -1,630,000 | 348,900,000 | -183,170,000 | ||
| Last Quarter Sales | 264,030,000 | 874,560,000 | 196,000,000 | ||
| Last Quarter Net Income | 30,810,000 | -46,570,000 | -28,560,000 | ||
| 60-Month Beta | 1.26 | 0.29 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.22 on 02/05/26 | 0.46 on 02/23/26 | -0.71 on 02/23/26 | ||
| Latest Earnings Date | 05/11/26 | 05/07/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 44.43 | 22.26 | 0.00 | ||